$GTI
GRAPHJET TECHNOLOGY Stock $gti

$gti Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000149315223009772 Filed on March 30, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$750.6K	$1.295M
YoY Change	152.12%	318.59%
Operating Profit		-$1.295M
YoY Change
Interest Expense	$652.4K	$1.349M
YoY Change	48227.41%	99796.3%
% of Operating Profit
Other Income/Expense, Net	-$90.00
YoY Change
Pretax Income	-$98.28K	$53.88K
YoY Change	-66.84%	-117.5%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	-$98.28K	$53.88K
YoY Change	-66.84%	-117.5%
Net Earnings / Revenue
Basic Earnings Per Share		$0.02
Diluted Earnings Per Share	-$0.03	$0.02
COMMON SHARES
Basic Shares Outstanding		3.403M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.79K	$47.79K
YoY Change	-99.96%	-93.32%
Cash & Equivalents	$47.79K
Short-Term Investments
Other Short-Term Assets	$143.1K	$143.1K
YoY Change	1804.93%	1804.93%
Inventory
Prepaid Expenses	$143.1K
Receivables
Other Receivables
Total Short-Term Assets	$361.4K	$361.4K
YoY Change	-50.02%	-50.02%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$19.54M	$19.54M
YoY Change	-83.26%	-83.26%
Other Assets
YoY Change
Total Long-Term Assets	$19.54M	$19.54M
YoY Change	-83.26%	-83.26%
TOTAL ASSETS
Total Short-Term Assets	$361.4K	$361.4K
Total Long-Term Assets	$19.54M	$19.54M
Total Assets	$19.90M	$19.90M
YoY Change	-83.06%	-83.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$686.2K	$686.2K
YoY Change	1464.12%	1464.17%
Deferred Revenue
YoY Change
Short-Term Debt	$259.1K	$259.1K
YoY Change	192.68%	192.68%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.085M	$1.085M
YoY Change	612.1%	612.11%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.025M	$4.025M
YoY Change	0.0%	0.0%
Total Long-Term Liabilities	$4.025M	$4.025M
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.085M	$1.085M
Total Long-Term Liabilities	$4.025M	$4.025M
Total Liabilities	$5.110M	$5.110M
YoY Change	22.33%	22.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.920M
YoY Change	42.47%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.919M	$14.79M
YoY Change
Total Liabilities & Shareholders Equity	$19.90M	$19.90M
YoY Change	-83.06%	-83.06%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$98.28K	$53.88K
YoY Change	-66.84%	-117.5%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$3.650K	-$667.9K
YoY Change	-98.49%	176.75%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$116.7M	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-3.650K	-$667.9K
Cash From Investing Activities	0.000
Cash From Financing Activities	0.000
Net Change In Cash	-3.650K	-$667.9K
YoY Change	-100.51%	-193.32%
FREE CASH FLOW
Cash From Operating Activities	-$3.650K	-$667.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001879373
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Other Receivables OtherReceivables		usd
CY2021Q4	ENCP	Extension Loan ExtensionLoan		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity		usd
	ENCP	Accretion Additional Paid In Capital Deficit AccretionAdditionalPaidInCapitalDeficit		usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable		usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	ENCP	Proceeds From Sale Of Units Net Of Underwriting Discount Paid ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountPaid		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	ENCP	Payment Of Accrued Expenses PaymentOfAccruedExpenses		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	ENCP	Extension Loan Receivable ExtensionLoanReceivable		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41070
CY2022	dei	Entity Registrant Name EntityRegistrantName	Energem Corp.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	Level 3, Tower 11, Avenue 5, No. 8
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Jalan Kerinchi, Bangsar South
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	Wilayah Persekutuan
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
CY2022	dei	Entity Address Country EntityAddressCountry	MY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	59200
CY2022	dei	City Area Code CityAreaCode	60
CY2022	dei	Local Phone Number LocalPhoneNumber	3270 47622
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022	dei	Auditor Name AuditorName	Adeptus Partners, LLC
CY2022	dei	Auditor Location AuditorLocation	Ocean, New Jersey
CY2022	dei	Auditor Firm AuditorFirmId	3686
CY2022Q4	us-gaap	Cash Cash	47789	usd
CY2021Q4	us-gaap	Cash Cash	715727	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	143055	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7505	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	170594	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	361438	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	723232	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	19535946	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	116726349	usd
CY2022Q4	us-gaap	Assets Assets	19897384	usd
CY2021Q4	us-gaap	Assets Assets	117449581	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	686195	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	43871	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	140000	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	20000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	88542	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	88542	usd
CY2022Q4	ENCP	Extension Loan ExtensionLoan	170594	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1085331	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	152413	usd
CY2022Q4	ENCP	Deferred Underwriting Commission DeferredUnderwritingCommission	4025000	usd
CY2021Q4	ENCP	Deferred Underwriting Commission DeferredUnderwritingCommission	4025000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5110331	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4177413	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	19706540	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	116725000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4919828	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3453173	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4919487	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3452832	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19897384	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	117449581	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1294712	usd
	us-gaap	Operating Expenses OperatingExpenses	309298	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1294712	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-309298	usd
CY2022	ENCP	Interest Income Loss InterestIncomeLoss	1348596	usd
	ENCP	Interest Income Loss InterestIncomeLoss	1349	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	53884	usd
	us-gaap	Net Income Loss NetIncomeLoss	-307949	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3403075	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3000454	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	115000000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5280750	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	6738148	usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-116725000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	12514	usd
	us-gaap	Net Income Loss NetIncomeLoss	-307949	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3452832	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3452832	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-59400	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3512232	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-12989	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3525221	usd
CY2022Q3	ENCP	Remeasurement For Ordinary Share To Redemption Amount RemeasurementForOrdinaryShareToRedemptionAmount	-697259	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	224556	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3998194	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3998194	usd
CY2022Q4	ENCP	Remeasurement For Ordinary Share To Redemption Amount RemeasurementForOrdinaryShareToRedemptionAmount	-652417	usd
CY2022Q4	us-gaap	Share Price SharePrice	0.045
CY2022Q4	ENCP	Stock Issued During Period Value Additional Amount Deposited Into Trust StockIssuedDuringPeriodValueAdditionalAmountDepositedIntoTrust	-170594	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-98282	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-98282	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4919487	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4919487	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	53884	usd
	us-gaap	Net Income Loss NetIncomeLoss	-307949	usd
CY2022	ENCP	Interest Income Loss InterestIncomeLoss	1348596	usd
	ENCP	Interest Income Loss InterestIncomeLoss	1349	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	11579	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	135550	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7505	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	642324	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	43871	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	120000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	20000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-667938	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-241353	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	116725000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-116725000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	303020	usd
	ENCP	Proceeds From Sale Of Units Net Of Underwriting Discount Paid ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountPaid	112725000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5280750	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	22197	usd
	ENCP	Payment Of Accrued Expenses PaymentOfAccruedExpenses	23453	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	117682080	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-667938	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	715727	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	715727	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47789	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	715727	usd
CY2022	ENCP	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	4025000	usd
	ENCP	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	4025000	usd
CY2022	ENCP	Value Of Class Ordinary Shares Subject To Redemption ValueOfClassOrdinarySharesSubjectToRedemption	19535946	usd
	ENCP	Value Of Class Ordinary Shares Subject To Redemption ValueOfClassOrdinarySharesSubjectToRedemption	116725000	usd
CY2022	ENCP	Extension Loan Receivable ExtensionLoanReceivable	170594	usd
CY2021Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	116725000	usd
CY2022Q4	us-gaap	Cash Cash	47789	usd
CY2022Q4	ENCP	Working Capital WorkingCapital	723893	usd
CY2022Q4	ENCP	Percentage Of Minimum Fair Market Value Of Net Asset Held In Trust Account PercentageOfMinimumFairMarketValueOfNetAssetHeldInTrustAccount	0.80	pure
CY2022Q4	ENCP	Minimum Post Business Combination Ownership MinimumPostBusinessCombinationOwnership	0.50	pure
CY2022Q4	ENCP	Redeeming Shares More Than Aggregate Percentage RedeemingSharesMoreThanAggregatePercentage	0.20	pure
CY2022Q4	ENCP	Redemptions In Connection With Business Combination To Redeem Percentage RedemptionsInConnectionWithBusinessCombinationToRedeemPercentage	1	pure
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2022Q4	us-gaap	Cash Cash	47789	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_z8OwZjyyeOPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zTgwjmcYUKm6">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	111444250	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5280750	usd
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2862500	shares
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	116726349	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_z94PyGULQYca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_867_zxtKUQ05hUWe">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zQd7111p4rm5" title="Federal depository insurance coverage amount">250,000</span>. On December 31, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.4pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	116725000	usd
CY2022	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	The initial shareholders have agreed not to transfer, assign or sell any of the Class B ordinary shares (except to certain permitted transferees) until, with respect to 50% of the Class B ordinary shares, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, with respect to the remaining 50% of the Class B ordinary shares, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022	ENCP	Share Adjustment Description ShareAdjustmentDescription	the Company issues additional shares of Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our sponsor or its affiliates, without taking into account any founder shares held by our sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial Business Combination on the date of the consummation of our initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of our Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which we consummate our initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11249740	shares
CY2022Q4	ENCP	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	11249740	shares

Files In Submission

Name	View Source	Status
encp-20221231_lab.xml	Edgar Link	unprocessable
encp-20221231_cal.xml	Edgar Link	unprocessable
encp-20221231_def.xml	Edgar Link	unprocessable
0001493152-23-009772-index-headers.html	Edgar Link	pending
0001493152-23-009772-index.html	Edgar Link	pending
0001493152-23-009772.txt	Edgar Link	pending
0001493152-23-009772-xbrl.zip	Edgar Link	pending
encp-20221231.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-5.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
encp-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTI
GRAPHJET TECHNOLOGY Stock $gti

2022 Q4 Form 10-K Financial Statement

#000149315223009772 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTI GRAPHJET TECHNOLOGY Stock $gti

2022 Q4 Form 10-K Financial Statement

#000149315223009772 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTI
GRAPHJET TECHNOLOGY Stock $gti